|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Odontiod laderal mass asymmetry:do We over - investigate 显示文摘 | Harty J A Lenehan B O' Rourke SK | 2005 | Emerg Med J2005，22，： | 1 |
| 2 | High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthe-sia:clinical and theoretic implications显示文摘 | Yaksh T L Harty G J Onofrio B M | 1986 | Anesthesiol1986，64，5： | 1 |
| 3 | Fluoride-induced oxida-tive stress in rat,s brain and its amelioration by buffalo(bubalus bubalis) pineal proteins and melatonin显示文摘 | Vijay K Harti B Srivastava RS | 2009 | Bio-logical Trace Element Research2009，130，2： | 1 |
| 4 | Effectof hot-rolling parameters on texture development and microstructure in aluminiumAA5182显示文摘 | Visser R F Wolff I M Harty B D | 1994 | Mater Sci Forum1994，1576，1： | 1 |
| 5 | Applications of brayton cycle tectmology to space power显示文摘 | HARTY R B OTTING W D KUDIJA C T | 1994 | JEEE Aerospace and Electronics Systems Magazine1994，9，1： | 1 |
| 6 | Odontoid lateral mass asymmetry:do we over-investigate显示文摘 | Harty JA Lenehan B O'Rourke SK | 2005 | Emerg Med J2005，22，： | 1 |
| 7 | Fluoride-Induced Oxidative Stress in Rat's Brain and Its Amelioration by Buffalo(Bubalus bubalis) Pineal Proteins and Melatonin显示文摘 | Vijay K Harti B Srivastava RS | 2009 | Biologieal Trace Element Research2009，130，2： | 1 |
| 8 | Odontoid lateral mass asymmetry:do we over-investigate?显示文摘 | Harty JA Lenehan B O'Rourke SK | 2005 | Emerg Med J2005，22，9： | 1 |
| 9 | Effects of crude oil on the supralittoral meiofauna of a sandy beach显示文摘 | McLACHLAN A HARTY B | 1982 | Marine Environmental Research1982，7，1： | 1 |
| 10 | Discussing general safety concerns in the laboratory 显示文摘 | B HARTY - GOLDER | 2002 | MLO Med Lab Obs2002，34，7： | 1 |
| 11 | Odontoid lateral mass asymmetry do we over-investigate显示文摘 | Harty JA Lenehan B OIRourke SK | 2005 | Emerg Med J2005，22，： | 1 |
| 12 | Real-world cure rates for hepatitis C virus treatments that include simeprevir and/or sofosbuvir are comparable to clinical trial results显示文摘AIM To assess the real-world effectiveness and cost of simeprevir(SMV), and/or sofosbuvir(SOF)-based therapy for chronic hepatitis C virus(HCV) infection.METHODS The real-world performance of patients treated with SMV/SOF ± ribavirin(RBV), SOF/RBV, and SOF/RBV with pegylated-interferon(PEG) were analyzed in a consecutive series of 508 patients with chronic HCV infection treated at a single academic medical center. Patients with genotypes 1 through 4 were included. Rates of sustained virological response-the absence of a detectable serum HCV RNA 12 wk after the end of treatment [sustained virological response(SVR) 12]-were calculated on an intention-to-treat basis. Costs were calculated from the payer's perspective using Medicare/Medicaid fees and Redbook Wholesale Acquisition Costs. Patient-related factors associated with SVR12 were identified using multivariable logistic regression.RESULTS SVR 12 rates were as follows: 86%(95%CI: 80%-91%)among 178 patients on SMV/SOF ± RBV; 62%(95%CI: 55%-68%) among 234 patients on SOF/RBV; and 78%(95%CI: 68%-86%) among 96 patients on SOF/PEG/RBV. Mean costs-per-SVR 12 were $174442(standard deviation: ± $18588) for SMV/SOF ± RBV; $223003(± $77946) for SOF/RBV; and $126496(± $31052) for SOF/PEG/RBV. Among patients on SMV/SOF ± RBV, SVR12 was less likely in patients previously treated with a protease inhibitor [odds ratio(OR): 0.20, 95%CI: 0.06-0.56]. Higher bilirubin(OR: 0.47, 95%CI: 0.30-0.69) reduced the likelihood of SVR12 among patients on SOF/RBV, while FIB-4 score ≥ 3.25 reduced the likelihood of SVR 12(OR: 0.18, 95%CI: 0.05-0.59) among those on SOF/PEG/RBV. CONCLUSION SVR 12 rates for SMV and/or SOF-based regimens in a diverse real-world population are comparable to those in clinical trials. Treatment failure accounts for 27% of costs. | Kian Bichoupan Neeta Tandon James F Crismale Joshua Hartman David Del Bello Neal Patel Sweta Chekuri Alyson Harty Michel Ng Keith M Sigel Meena B Bansal Priya Grewal Charissa Y Chang Jennifer Leong Gene Y Im Lawrence U Liu Joseph A Odin Nancy Bach Scott L Friedman Thomas D Schiano Ponni V Perumalswami Douglas T Dieterich Andrea D Branch | 2017 | World Journal of Virology2017，6，4： | 1 |
| 13 | Odontoid lateral mass asymmetry:do we over-investigate? 显示文摘 | Harty J A Lenehan B O'Rourke S K | 2005 | Emerg Med J2005，22，9： | 1 |
| 14 | Odontoid lateral mass asymmetry: do we over-investigate显示文摘 | Harty J A Lenehan B O'Rourke SK | 2005 | Emerg Med J2005，22，： | 1 |
| 15 | Anesthesia for electroconvulsine therapy : propofol versusthiopental 显示文摘 | Harti A Hmamouchi B Idali H | 2001 | Encephale2001，27，： | 1 |
| 16 | Applications of Brayton Cycle Technology to Space Power 显示文摘 | Otting W D Kudija C T | 1994 | IEEE Aerospace and Electronics Systems Magazine1994，9，1： | 1 |
| 17 | Anesehesia for electroconvulsive therapy : propofol versus thiopenta 显示文摘 | HARTI A HMAMOUCHI B IDALI H | 2001 | Encephale2001，27，3： | 1 |
| 18 | Lung airway-surveilling CXCR3 memory CD8^+ T cells are critical for protection against influenza a virus显示文摘 | Slutter B Pewe L L Kaech S M Harty J T | 2013 | Im- munity2013，39，5： | 1 |
| 19 | Fluoride-induced oxida-tive stress in rat,s brain and its amelioration by buffalo(bubalus bubalis) pineal proteins and melatonin显示文摘 | Vijay K Harti B Srivastava RS | 2009 | Bio-logical Trace Element Research2009，130，2： | 1 |
| 20 | A new rank-based version of the Ant System:A computational study显示文摘 | Bullnheimer B HartI R F Strauss C C | 1999 | Central European Journal for Operations Research and Economics1999，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员